Lablytica exhibition at KI Science Park DAY

nov 12, 2024

Lablytica will have an exhibition at KI Science Park DAY hosted by KI Science Park in Solna this Wednesday.

At KI Science Park DAY innovation, growth and collaboration take center stage—startups connect with scaleups, academia connect with business, emerging talent meets seasoned experts, and knowledge flows freely. If you’re active in the Life Science sector, we invite you to join us for a day of inspiration and opportunity!

As an Uppsala bioanalysis company, we at Lablytica care about growing the life science sector, and increasing local collaboration, between the Stockholm and Uppsala regions.

Come meet Kristi House and Stefan Martinsson from the Lablytica team for a discussion on how we can help you achieve your bioanalysis needs!

You might also like

CTR launches podcast together with SwedenBIO

CTR launches podcast together with SwedenBIO

The first episode of the podcast Idé till patient (Idea to patient) will be released on April 12. The podcast series is a co-production between the companies within the CTR-group and SwedenBIO. The series comprises six episodes where invited guests from the pharma...

CTR acquires preclinical toxicology company

CTR acquires preclinical toxicology company

Center for Translational Research Sweden AB (CTR) acquires Toxicology Knowledge Team Sweden AB (TKT) further strengthening the CTR group with optimised toxicological support. From April 1, TKT is a fully owned subsidiary to the holding company CTR. The activities at...

CTR launches podcast together with SwedenBIO

The first episode of the podcast Idé till patient (Idea to patient) will be released on April 12. The podcast series is a co-production between the companies within the CTR-group and SwedenBIO. The series comprises six episodes where invited guests from the pharma...

CTR acquires preclinical toxicology company

Center for Translational Research Sweden AB (CTR) acquires Toxicology Knowledge Team Sweden AB (TKT) further strengthening the CTR group with optimised toxicological support. From April 1, TKT is a fully owned subsidiary to the holding company CTR. The activities at...

New statement of OECD GLP compliance

Happy and proud to share that Lablytica has just received their new statement of OECD GLP compliance for Analytical and Clinical Chemistry testing (8) from SWEDACs inspection on the 10 November 2020....

David Pekar becomes CEO at Lablytica

Lablytica Life Science AB started in November 2019 when Recipharm’s GLP bioanalysis business was divested to Center for Translational Research AB (CTR). David Pekar has since then been the Site Manager and Chief Scientific Officer at Lablytica. As announced by CTR,...